The pharmaceutical group will invest in oncology and dermatology companies, startups and laboratories through the Pierre Fabre Fund for Innovation.

France-based pharmaceutical firm Pierre Fabre is set to begin investing in startups through a recently formed open innovation initiative called Pierre Fabre Fund for Innovation.

The fund will look to back oncology or dermatology-focused biotech companies, startups and research laboratories conducting research and development projects that are in the early stages of clinical development, or which are set to enter clinical testing within two years.

Bertrand Parmentier, Pierre Fabre Group’s CEO, explained: “With Pierre Fabre Fund for Innovation we have…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?